BA
NVCR icon

BlackRock Advisors’s NovoCure NVCR Stock Holding History

BlackRock Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$144K Sell
18,334
-1
-0% -$8 ﹤0.01% 2874
2016
Q3 		$157K Buy
18,335
+1,751
+11% +$16K ﹤0.01% 2808
2016
Q2 		$194K Buy
16,584
+14,152
+582% +$177K ﹤0.01% 2624
2016
Q1 		$35K Hold
2,432
– – ﹤0.01% 3269
2015
Q4 		$54K Buy
+2,432
New +$58.1K ﹤0.01% 3160

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's NVCR Position: Q4 2016 in Review

BlackRock Advisors reduced its NovoCure (NVCR) stake by 0.01% in Q4 2016, selling an estimated $8 and leaving 18,334 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

BlackRock Advisors first reported a position in NVCR in Q4 2015 and has held it in 5 quarters since. The position peaked at $194K in Q2 2016. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

  • BlackRock Advisors held 18,334 shares of NovoCure worth $144K as of Q4 2016.
  • BlackRock Advisors sold 1 NovoCure share in Q4 2016, an estimated $8.
  • NovoCure made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2874 holding.
  • BlackRock Advisors first reported a position in NovoCure in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's NovoCure position peaked at $194K in Q2 2016.
  • 78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.